Sona Nanotech's Targeted Hyperthermia Therapy To Be Presented at the International 19th Canadian Melanoma Conference Technology Investing Feb 12, 2025 03:24AM PST
Sona Nanotech's THT Cancer Therapy Preclinical Efficacy Studies Published In Peer-Reviewed Scientific Journal Technology Investing Jan 13, 2025 04:22AM PST
Sona Nanotech's THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study Technology Investing Dec 11, 2024 04:01AM PST
Sona Nanotech to Showcase Its THT Cancer Therapy at NCL 20th Anniversary Symposium and Provides Corporate Update Technology Investing Nov 7, 2024 03:15AM PST
Sona Nanotech Issued Patent and Appoints New Board Member Technology Investing Oct 21, 2024 11:32AM PST
Sona Nanotech Closes Private Placement Financing to Raise $1,643,750 in Gross Proceeds Technology Investing Sep 24, 2024 03:47AM PST
Sona Nanotech Closes Private Placement Financing to Raise $1,500,000 in Gross Proceeds and Announces Additional Financing Technology Investing Sep 5, 2024 03:25AM PST
Sona Nanotech (CSE:SONA) Sona Nanotech to Arrange Private Placement Financing Technology Investing Jul 31, 2024 03:22AM PST
Sona Nanotech (CSE:SONA) Sona's Cancer Therapy Triggers Abscopal Effect, Eliminating Distant Tumors In Preclinical Melanoma Study Technology Investing Jun 26, 2024 04:54AM PST